What its about A Senior Auditorspecialized inData & AIbridges deep technical expertise with internal audit practice, using data, AI, and modern tooling to sharpen risk identification, surface anomalies, and elevate the quality of audit insights. This
Position Summary: The EU CTR Submission Lead is responsible for leading and overseeing the full lifecycle of regulatory submissions for clinical trials conducted under the EU Clinical Trial Regulation (EU CTR 536/2014) via the Clinical Trials
About This Role The Senior Director, Alzheimer’s Global Diagnostics & Disease Area Strategy, will lead the overall global AD diagnostic pathway strategy and disease area strategy for the Alzheimer’s Disease and Dementia Franchise. Significant collaboration is
Join us as a R&D Project Portfolio Manager. In this role, you will drive portfolio governance, oversee end-to-end project delivery, and apply strong project management expertise to ensure successful outcomes. You will connect strategy with execution
What its about Financial Planning & Analysis (FP&A) is a key function at Partners Group. This team plays a key part in the companys planning and control cycle and drives business analytics to support decision making
What its about Partners Group is seeking a Senior Associate to join our high-performing and expanding Private Credit investment team in Stockholm. This is an opportunity for you to shape the future of Partners Group’s European
What its about Partners Group has been a leading innovator of client solutions for the Private Wealth segment. In this segment, Partners Group caters via wholesale/distribution sales channels to private wealth clients. The firm has been
At Novocure, every role contributes to extending the lives of people living with cancer. As our new Senior Director, Clinical Regulatory Affairs, you’ll play a key part in this mission. This is a highly visible global
Acadia Pharmaceuticals is a company dedicated to innovation in neurological and rare disease therapies. Our portfolio includes the first FDA‑approved treatments for Parkinson’s disease psychosis and Rett syndrome, and we are developing additional programs in Alzheimer’s disease